omnipaque- iohexol injection, solution
ge healthcare inc. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - iodine 300 mg in 1 ml - omnipaque 300 is indicated for intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography). omnipaque should not be administered to patients with a known hypersensitivity to iohexol. myelography should not be performed in the presence of significant local or systemic infection where bacteremia is likely. intrathecal administration of corticosteroids with omnipaque is contraindicated. because of the possibility of overdosage, immediate repeat myelography in the event of technical failure is contraindicated (see dosage and administration). omnipaque 350 is indicated in adults for angiocardiography (ventriculography, selective coronary arteriography), aortography including studies of the aortic root, aortic arch, ascending aorta, abdominal aorta and its branches, intravenous digital subtraction angiography of the head, neck, abdominal, renal and peripheral vessels, p
omnipaque- iohexol injection, solution
ge healthcare inc. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - omnipaque 300 is indicated for intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography). omnipaque should not be administered to patients with a known hypersensitivity to iohexol. myelography should not be performed in the presence of significant local or systemic infection where bacteremia is likely. intrathecal administration of corticosteroids with omnipaque is contraindicated. because of the possibility of overdosage, immediate repeat myelography in the event of technical failure is contraindicated (see dosage and administration). omnipaque 350 is indicated in adults for angiocardiography (ventriculography, selective coronary arteriography), aortography including studies of the aortic root, aortic arch, ascending aorta, abdominal aorta and its branches, intravenous digital subtraction angiography of the head, neck, abdominal, renal and peripheral vessels
omniscan
ge healthcare australia pty ltd - gadodiamide -
omnipaque
ge healthcare limited - iohexol 518 mg/ml equivalent to 240 mg i/ml - solution for injection - 240 mg i/ ml - active: iohexol 518 mg/ml equivalent to 240 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.
omnipaque
ge healthcare limited - iohexol 647 mg/ml equivalent to 300 mg i/ml - solution for injection - 300 mg i/ ml - active: iohexol 647 mg/ml equivalent to 300 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.
omnipaque
ge healthcare limited - iohexol 755 mg/ml equivalent to 350 mg i/ml - solution for injection - 350 mg i/ ml - active: iohexol 755 mg/ml equivalent to 350 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.
vesomni 6 mg/0.4 mg modified release tablets
lexon (uk) ltd - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and solifenacin
vesomni 6 mg/0.4 mg modified-release tablets
lexon pharmaceuticals (ireland) limited - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and solifenacin
omnic ocas 0.4 prolonged release film-coated tablets
astellas pharma europe b.v. - tamsulosin hydrochloride - film-coated tablet - tamsulosin hydrochloride 0.4 milligram(s) - urologicals
nutra-life meno-life day + night
vitaco health australia pty ltd - actaea racemosa,angelica polymorpha,calcium citrate tetrahydrate,eleutherococcus senticosus,glycine max,heavy magnesium oxide,hypericum perforatum,passiflora incarnata,trifolium pratense,valeriana officinalis,vitex agnus-castus -